163 related articles for article (PubMed ID: 25895985)
1. Genetic Variation in TLR10, an Inhibitory Toll-Like Receptor, Influences Susceptibility to Complicated Skin and Skin Structure Infections.
Stappers MH; Oosting M; Ioana M; Reimnitz P; Mouton JW; Netea MG; Gyssens IC; Joosten LA
J Infect Dis; 2015 Nov; 212(9):1491-9. PubMed ID: 25895985
[TBL] [Abstract][Full Text] [Related]
2. TLR1, TLR2, and TLR6 gene polymorphisms are associated with increased susceptibility to complicated skin and skin structure infections.
Stappers MH; Thys Y; Oosting M; Plantinga TS; Ioana M; Reimnitz P; Mouton JW; Netea MG; Joosten LA; Gyssens IC
J Infect Dis; 2014 Jul; 210(2):311-8. PubMed ID: 24511099
[TBL] [Abstract][Full Text] [Related]
3. Genetic variation in TLR10 is not associated with chronic Q fever, despite the inhibitory effect of TLR10 on Coxiella burnetii-induced cytokines in vitro.
Ammerdorffer A; Stappers MH; Oosting M; Schoffelen T; Hagenaars JC; Bleeker-Rovers CP; Wegdam-Blans MC; Wever PC; Roest HJ; van de Vosse E; Netea MG; Sprong T; Joosten LA
Cytokine; 2016 Jan; 77():196-202. PubMed ID: 26364993
[TBL] [Abstract][Full Text] [Related]
4. Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk.
Sun J; Wiklund F; Zheng SL; Chang B; Bälter K; Li L; Johansson JE; Li G; Adami HO; Liu W; Tolin A; Turner AR; Meyers DA; Isaacs WB; Xu J; Grönberg H
J Natl Cancer Inst; 2005 Apr; 97(7):525-32. PubMed ID: 15812078
[TBL] [Abstract][Full Text] [Related]
5. Extensive polymorphism in the porcine Toll-like receptor 10 gene.
Bergman IM; Edman K; Ekdahl KN; Rosengren KJ; Edfors I
Int J Immunogenet; 2012 Feb; 39(1):68-76. PubMed ID: 22077964
[TBL] [Abstract][Full Text] [Related]
6. Genetic variation in the toll-like receptor gene cluster (TLR10-TLR1-TLR6) and prostate cancer risk.
Stevens VL; Hsing AW; Talbot JT; Zheng SL; Sun J; Chen J; Thun MJ; Xu J; Calle EE; Rodriguez C
Int J Cancer; 2008 Dec; 123(11):2644-50. PubMed ID: 18752252
[TBL] [Abstract][Full Text] [Related]
7. The role of Toll-like receptor 10 in modulation of trained immunity.
Mourits VP; Arts RJW; Novakovic B; Matzaraki V; de Bree LCJ; Koeken VACM; Moorlag SJCFM; van Puffelen JH; Groh L; van der Heijden CDCC; Keating ST; Netea MG; Oosting M; Joosten LAB
Immunology; 2020 Mar; 159(3):289-297. PubMed ID: 31671203
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms in cytokine genes IL6, TNF, IL10, IL17A and IFNG influence susceptibility to complicated skin and skin structure infections.
Stappers MH; Thys Y; Oosting M; Plantinga TS; Ioana M; Reimnitz P; Mouton JW; Netea MG; Joosten LA; Gyssens IC
Eur J Clin Microbiol Infect Dis; 2014 Dec; 33(12):2267-74. PubMed ID: 25022448
[TBL] [Abstract][Full Text] [Related]
9. Human TLR10 is an anti-inflammatory pattern-recognition receptor.
Oosting M; Cheng SC; Bolscher JM; Vestering-Stenger R; Plantinga TS; Verschueren IC; Arts P; Garritsen A; van Eenennaam H; Sturm P; Kullberg BJ; Hoischen A; Adema GJ; van der Meer JW; Netea MG; Joosten LA
Proc Natl Acad Sci U S A; 2014 Oct; 111(42):E4478-84. PubMed ID: 25288745
[TBL] [Abstract][Full Text] [Related]
10. Association of Toll-like receptor 10 and susceptibility to Crohn's disease independent of NOD2.
Abad C; González-Escribano MF; Diaz-Gallo LM; Lucena-Soto JM; Márquez JL; Leo E; Crivell C; Gómez-García M; Martín J; Núñez-Roldán A; García-Lozano JR
Genes Immun; 2011 Dec; 12(8):635-42. PubMed ID: 21716313
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms in TLR1, TLR6 and TLR10 genes and the risk of Graves' disease.
Xiao W; Liu Z; Lin J; Li J; Wu K; Ma Y; Gong Y; Liu Z
Autoimmunity; 2015 Feb; 48(1):13-8. PubMed ID: 25028161
[TBL] [Abstract][Full Text] [Related]
12. Association between Toll-like receptor gene cluster (TLR6, TLR1, and TLR10) and prostate cancer.
Chen YC; Giovannucci E; Kraft P; Lazarus R; Hunter DJ
Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):1982-9. PubMed ID: 17932345
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor 1 variations influence susceptibility and immune response to Mycobacterium tuberculosis.
Dittrich N; Berrocal-Almanza LC; Thada S; Goyal S; Slevogt H; Sumanlatha G; Hussain A; Sur S; Burkert S; Oh DY; Valluri V; Schumann RR; Conrad ML
Tuberculosis (Edinb); 2015 May; 95(3):328-35. PubMed ID: 25857934
[TBL] [Abstract][Full Text] [Related]
14. Genetic variation in the Toll-like receptor gene cluster (TLR10-TLR1-TLR6) influences disease course in sarcoidosis.
Veltkamp M; van Moorsel CH; Rijkers GT; Ruven HJ; Grutters JC
Tissue Antigens; 2012 Jan; 79(1):25-32. PubMed ID: 22150367
[TBL] [Abstract][Full Text] [Related]
15. Toll-like receptor 10 is involved in induction of innate immune responses to influenza virus infection.
Lee SM; Kok KH; Jaume M; Cheung TK; Yip TF; Lai JC; Guan Y; Webster RG; Jin DY; Peiris JS
Proc Natl Acad Sci U S A; 2014 Mar; 111(10):3793-8. PubMed ID: 24567377
[TBL] [Abstract][Full Text] [Related]
16. 1,25-Dihydroxyvitamin D3 up-regulates TLR10 while down-regulating TLR2, 4, and 5 in human monocyte THP-1.
Verma R; Jung JH; Kim JY
J Steroid Biochem Mol Biol; 2014 May; 141():1-6. PubMed ID: 24373795
[TBL] [Abstract][Full Text] [Related]
17. Meat and fiber intake and interaction with pattern recognition receptors (TLR1, TLR2, TLR4, and TLR10) in relation to colorectal cancer in a Danish prospective, case-cohort study.
Kopp TI; Vogel U; Tjonneland A; Andersen V
Am J Clin Nutr; 2018 Mar; 107(3):465-479. PubMed ID: 29566186
[TBL] [Abstract][Full Text] [Related]
18. Increased Expression of the Innate Immune Receptor TLR10 in Obesity and Type-2 Diabetes: Association with ROS-Mediated Oxidative Stress.
Sindhu S; Akhter N; Kochumon S; Thomas R; Wilson A; Shenouda S; Tuomilehto J; Ahmad R
Cell Physiol Biochem; 2018; 45(2):572-590. PubMed ID: 29428931
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms in Toll-Like Receptor 10 and Tuberculosis Susceptibility: Evidence from Three Independent Series.
Wang Y; Zhang MM; Huang WW; Wu SQ; Wang MG; Tang XY; Sandford AJ; He JQ
Front Immunol; 2018; 9():309. PubMed ID: 29527210
[TBL] [Abstract][Full Text] [Related]
20. TLR10: Insights, controversies and potential utility as a therapeutic target.
Su SB; Tao L; Deng ZP; Chen W; Qin SY; Jiang HX
Scand J Immunol; 2021 Apr; 93(4):e12988. PubMed ID: 33047375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
